Efficacy and Safety of Methylprednisolone for Lung Surgery: a Systematic Review and Meta-analysis of Randomized Controlled Trials

Abstract

Introduction:The administration of methylprednisolone (MP) is a component of perioperative multimodal analgesia that mitigates the potentially deleterious effects of postoperative pain and opioid consumption. However, a systematic evaluation of the efficacy and safety of MP is lacking. The present systematic review and meta-analysis was performed to quantify the potential clinical benefits and risks of perioperative MP in lung surgery. Methods: We searched seven electronic databases for randomized controlled trials (RCTs) comparing MP with placebo. Coprimary outcomes were rest pain scores, dynamic pain scores, and cumulative morphine equivalent consumption within 24 h postoperatively. Results: A total of 11 trials including 643 participants were selected for our meta-analysis. The results demonstrated that the MP group had a significant difference in coprimary outcomes (rest pain scores, dynamic pain scores, and cumulative morphine equivalent consumption) compared with the placebo group; nevertheless, the improvement was not clinically meaningful based on minimum clinically important differences (MCID). Notably, MP administration reduced serum levels of interleukin (IL)-6 at 6 h (weighted mean difference -20.49 pg/mL; 95% CI -29.94 to -11.04), and decreased the incidence rate of acute lung injury (rate ratio 0.18; 95% CI 0.03-0.98) and cognitive dysfunction (rate ratio 0.43; 95% CI 0.21-0.88) compared with the placebo group. Conclusions: Our findings suggest that the administration of MP contributed to an insignificant relief in acute postoperative pain for lung surgery in a clinical setting. Future studies should focus on exploring the role of MP in reducing pulmonary and surgical-related complications after lung surgery.Xi Fu and Xin Ye contributed equally as co-first authors.Yi-Feng Ren, Jing Dong, and Xin Ye contributed equally as co-correspondence authors.

Effect of Preoperative Single-Dose Methylprednisolone Administration on Early Postoperative Pain Following Retrograde Intrarenal Surgery

“…However, the relationship between the use of steroids and an increased risk of infection remains unclear. According to the several meta-analyses, no signi cant difference was found in infection rates between the groups treated with systemic corticosteroids and those not treated with corticosteroids [34,35]. In addition, Grijalva et al showed that the risk of infection was associated with the dose of steroids.…”

Vitamin K2 (MK-7) attenuates LPS-induced acute lung injury via inhibiting inflammation, apoptosis, and ferroptosis

“…However, currently, there are no efficient drugs or therapies for LPS-induced ALI in clinical practice. A promising strategy to prevent and treat ALI is to suppress the excessive production of inflammatory cytokines through anti-inflammatory drugs, including corticosteroids, such as methylprednisolone [10], dexamethasone (DEX) [11], prednisolone [12]. However, the clinical application of corticosteroids is usually accompanied by various severe side effects, such as hyperglycemia, hypertension, hypokalemia, dyslipidemia, osteoporosis, myopathy and immunosuppression [13][14][15].…”